Tarsus Pharmaceuticals, Inc.
TARS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13 | -$20 | -$25 | -$23 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12 | $8 | $7 | $7 |
| Change in WC | $19 | -$16 | -$2 | -$6 |
| Other Non-Cash | -$1 | -$1 | -$1 | -$1 |
| Operating Cash Flow | $18 | -$29 | -$21 | -$22 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$1 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$102 | -$130 | -$126 | -$90 |
| Inv. Sales/Matur. | $100 | $79 | $91 | $35 |
| Other Inv. Act. | $0 | $0 | $0 | -$5 |
| Investing Cash Flow | -$5 | -$52 | -$35 | -$60 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$32 |
| Stock Issued | $3 | $2 | $137 | $3 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $32 |
| Financing Cash Flow | $3 | $2 | $137 | $3 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $16 | -$79 | $81 | -$79 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $99 | $178 | $97 | $176 |
| End Cash | $115 | $99 | $178 | $97 |
| Free Cash Flow | $16 | -$30 | -$21 | -$27 |